Table 4.
No. | Modification | Blood plasma | Liver homogenate | |||
---|---|---|---|---|---|---|
N-terminal | Side chain | t1/2±SEM [h] | P value[a] | t1/2±SEM [h] | P value[a] | |
14b | TAMRA | – | 84.7 ± 2.3 | – | 11.0 ± 0.4 | – |
15b | TAMRA | E-Prop | 473.6 ± 17.3 | ≤ 0.001 | 46.7 ± 6.6 | ≤0.01 |
16b | TAMRA | E-Capr | 281.3 ± 26.7 | ≤0.01 | 14.6 ± 2.8 | ns |
18b | TAMRA | E-Pam | 1088.1 ± 282.4 | ≤ 0.001 | 11.8± 0.8 | ns |
20 | – | TAMRA | 136.0 ± 3.1 | ns | 19.7 ± 0.4 | ns |
Statistical significance of t1/2 values was determined by one-way ANOVA, followed by Dunnett's post-hoc test (GraphPad Prism 5.0) with comparison to control peptide 14b; ns: not significant.